See All Slides - tctmd.com

Slides

Presentation TCT 2013

Impact of Intravascular Imaging on Interventional Therapies: Lessons learned and Future Directions

Presenter: Patrick Serruys

October 31, 2013

Presentation TCT 2013

Is Intraprocedural TEE During TAVR a Luxury or a Necessity?

Presenter: Rebecca Hahn

October 31, 2013

Presentation TCT 2013

Case 1: Aggressive Lesion Preparation With Rotational Atherectomy Prior to Scaffolding

Presenter: Robert-Jan van Geuns

October 31, 2013

Presentation TCT 2013

Coronary Perforation: Causes and Acute Management

Presenter: David Cox

October 31, 2013

Presentation TCT 2013

Complex Congenital Heart Disease Intervention: Year in Review

Presenter: Frank Ing

October 31, 2013

Presentation TCT 2013

Does Dabigatran Increase MI in Patients with Coronary Artery Disease? Addressing the Current Controversy

Presenter: Michael Ezekowitz

October 31, 2013

Presentation TCT 2013

Optimal DAPT Duration Is Not Established: For Now Most Patients Should Stay on DAPT for at Least One Year!

Presenter: Edoardo Camenzind

October 31, 2013

Presentation TCT 2013

I'm Not So Sure: Bivalirudin Plus a Potent Oral ADP Antagonist Is All You Need!

Presenter: Frederick Feit

October 31, 2013

Presentation

A Collaboration in Adult Congenital Cardiac Care; Valve-in-Valve Transcatheter Edwards Sapien™ Implantation In A Degenerated Stenotic Hancock Conduit After A Fontan Björk...

Presenter: Huangling Lu

October 31, 2013

Presentation

Design and Function of Perfused Cadaveric Specimens for the Cardiovascular System

Presenter: Dmitry Levin

October 31, 2013

Advertisement

Slides

Impact of Intravascular Imaging on Interventional Therapies: Lessons learned and Future Directions

Is Intraprocedural TEE During TAVR a Luxury or a Necessity?

Case 1: Aggressive Lesion Preparation With Rotational Atherectomy Prior to Scaffolding

Coronary Perforation: Causes and Acute Management

Complex Congenital Heart Disease Intervention: Year in Review

Does Dabigatran Increase MI in Patients with Coronary Artery Disease? Addressing the Current Controversy

Optimal DAPT Duration Is Not Established: For Now Most Patients Should Stay on DAPT for at Least One Year!

I'm Not So Sure: Bivalirudin Plus a Potent Oral ADP Antagonist Is All You Need!

A Collaboration in Adult Congenital Cardiac Care; Valve-in-Valve Transcatheter Edwards Sapien™ Implantation In A Degenerated Stenotic Hancock Conduit After A Fontan Björk...

Design and Function of Perfused Cadaveric Specimens for the Cardiovascular System

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content